Abbvie Inc
NYSE: ABBV
$178.39
+$2.81 (+1.6%)
Closing Price on December 23, 2024
ABBV Articles
Thursday afternoon's top analyst upgrades and downgrades included AbbVie, Allstate, Amgen, Occidental Petroleum, Pfizer, SunPower, Twilio and Yum! Brands.
Published:
Shares of five top established and mature biotechnology and pharmaceutical companies have been hit hard and are offering some of the best entry points in months. The stocks also are rated Buy at top...
Published:
Now is the time to reduce risk and more to safer ideas. Top-quality health care stocks may be the way to go for the rest of 2021 and in 2022, and these five Dividend Aristocrats make good sense now...
Published:
Last Updated:
Tuesday's top analyst upgrades and downgrades included AbbVie, Altice USA, Amazon.com, Comcast, General Electric, Kimco Realty, Micron Technology, Nvidia, Salesforce.com, StoneCo, Western Digital,...
Published:
Health care is poised to benefit from a shift toward more defensive sectors. These five stocks have strong balance sheets, attractive dividend yields and improved cost structures. With even moderate...
Published:
In this massively overbought market, health care stocks could benefit from a shift toward more defensive sectors. These five offer strong balance sheets, attractive dividend yields and improved cost...
Published:
These five top companies are expected to lift the dividends they pay to shareholders, and their stocks are rated Buy across Wall Street, making them excellent total return candidates.
Published:
Hedge fund managers are getting more defensive, and it is probably high-time individual investors do as well. These five stocks come with reliable dividends, are not overextended and are rated Buy at...
Published:
With a bloated and overbought market, and the lack of a 5% correction in almost a year, shifting to some of the most dependable dividend-paying stocks makes sense now. These five Dividend Aristocrats...
Published:
24/7 Wall St. reviews dozens of analyst research reports each day of the week with a goal of finding new ideas for investors and traders alike. The calls seen in the past week show that analysts...
Published:
Last Updated:
These four big pharmaceutical stocks are rated Buy by top Wall Street firms and look like very good ideas for investors, especially now that the market is overbought and the slow seasonal market...
Published:
Tuesday's top analyst upgrades and downgrades included AbbVie, Alibaba, American Airlines, AT&T, Chipotle Mexican Grill, JD.com, Kimberly-Clark, Pfizer, Starbucks and Weyerhaeuser.
Published:
With bond yields remaining at generational lows, and the prospect of them going meaningfully higher in the near term seemingly off the table, it makes sense for growth and income investors to...
Published:
24/7 Wall St. takes a look at famed market personality Jim Cramer’s latest buy and sell recommendations and overall analysis.
Published:
With the potential for a sizable correction looming and interest rates at the lowest levels since February, it may be a good idea for investors to consider Dividend Aristocrats that are in sectors...
Published: